OnKure Therapeutics (OKUR) Competitors $3.00 -0.04 (-1.32%) Closing price 04:00 PM EasternExtended Trading$3.00 +0.00 (+0.17%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock OKUR vs. MDWD, IVA, GNFT, RZLT, ACIU, HURA, DBVT, NBTX, DMAC, and CGCShould you be buying OnKure Therapeutics stock or one of its competitors? The main competitors of OnKure Therapeutics include MediWound (MDWD), Inventiva (IVA), Genfit (GNFT), Rezolute (RZLT), AC Immune (ACIU), TuHURA Biosciences (HURA), DBV Technologies (DBVT), Nanobiotix (NBTX), DiaMedica Therapeutics (DMAC), and Canopy Growth (CGC). These companies are all part of the "pharmaceutical products" industry. OnKure Therapeutics vs. MediWound Inventiva Genfit Rezolute AC Immune TuHURA Biosciences DBV Technologies Nanobiotix DiaMedica Therapeutics Canopy Growth OnKure Therapeutics (NASDAQ:OKUR) and MediWound (NASDAQ:MDWD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, community ranking, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Does the MarketBeat Community prefer OKUR or MDWD? MediWound received 390 more outperform votes than OnKure Therapeutics when rated by MarketBeat users. However, 100.00% of users gave OnKure Therapeutics an outperform vote while only 62.23% of users gave MediWound an outperform vote. CompanyUnderperformOutperformOnKure TherapeuticsOutperform Votes7100.00% Underperform VotesNo VotesMediWoundOutperform Votes39762.23% Underperform Votes24137.77% Does the media refer more to OKUR or MDWD? In the previous week, MediWound had 2 more articles in the media than OnKure Therapeutics. MarketBeat recorded 3 mentions for MediWound and 1 mentions for OnKure Therapeutics. MediWound's average media sentiment score of 0.87 beat OnKure Therapeutics' score of -0.42 indicating that MediWound is being referred to more favorably in the news media. Company Overall Sentiment OnKure Therapeutics Neutral MediWound Positive Do analysts recommend OKUR or MDWD? OnKure Therapeutics currently has a consensus price target of $32.33, indicating a potential upside of 977.78%. MediWound has a consensus price target of $31.33, indicating a potential upside of 91.64%. Given OnKure Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe OnKure Therapeutics is more favorable than MediWound.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OnKure Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.40MediWound 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders believe in OKUR or MDWD? 91.0% of OnKure Therapeutics shares are owned by institutional investors. Comparatively, 46.8% of MediWound shares are owned by institutional investors. 17.9% of OnKure Therapeutics shares are owned by insiders. Comparatively, 9.2% of MediWound shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility & risk, OKUR or MDWD? OnKure Therapeutics has a beta of 0.35, indicating that its share price is 65% less volatile than the S&P 500. Comparatively, MediWound has a beta of 0.5, indicating that its share price is 50% less volatile than the S&P 500. Is OKUR or MDWD more profitable? OnKure Therapeutics has a net margin of 0.00% compared to MediWound's net margin of -142.29%. OnKure Therapeutics' return on equity of -51.17% beat MediWound's return on equity.Company Net Margins Return on Equity Return on Assets OnKure TherapeuticsN/A -51.17% -47.11% MediWound -142.29%-82.17%-33.67% Which has preferable earnings and valuation, OKUR or MDWD? MediWound has higher revenue and earnings than OnKure Therapeutics. MediWound is trading at a lower price-to-earnings ratio than OnKure Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOnKure TherapeuticsN/AN/A-$77.39M-$6.57-0.46MediWound$20.22M8.74-$6.72M-$3.07-5.33 SummaryOnKure Therapeutics beats MediWound on 9 of the 17 factors compared between the two stocks. Remove Ads Get OnKure Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OKUR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OKUR vs. The Competition Export to ExcelMetricOnKure TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$40.31M$6.32B$5.33B$7.57BDividend YieldN/A3.23%5.11%4.32%P/E Ratio-0.256.7921.7317.81Price / SalesN/A225.96379.2094.61Price / CashN/A65.6738.1534.64Price / Book0.115.866.464.00Net Income-$77.39M$141.86M$3.20B$247.23M7 Day Performance-2.28%8.98%6.54%7.26%1 Month Performance-34.92%-12.65%-8.55%-6.26%1 Year PerformanceN/A-11.99%10.33%-0.18% OnKure Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OKUROnKure Therapeutics2.8876 of 5 stars$3.00-1.3%$32.33+977.8%N/A$40.31MN/A-0.25N/AMDWDMediWound1.4034 of 5 stars$15.08+0.7%$31.33+107.8%+3.8%$162.76M$20.22M-5.2080Gap UpIVAInventiva2.1309 of 5 stars$3.10+1.0%$12.00+287.1%-7.3%$162.68M$9.20M0.00100Gap DownGNFTGenfit1.556 of 5 stars$3.25-3.4%$13.00+300.6%-3.4%$162.24M$76.06M0.00120News CoverageGap DownRZLTRezolute2.8751 of 5 stars$2.64+4.3%$24.38+823.3%-4.8%$159.81MN/A-2.1640Positive NewsGap DownACIUAC Immune2.5215 of 5 stars$1.59-4.2%$12.00+654.7%-44.5%$159.65M$27.31M-3.46140Analyst RevisionGap DownHURATuHURA BiosciencesN/A$3.64+7.7%$12.67+248.0%N/A$159.00MN/A0.00N/AGap DownDBVTDBV Technologies2.6077 of 5 stars$7.44+14.5%$22.50+202.4%+12.2%$153.03M$15.73M-1.6580Earnings ReportAnalyst ForecastShort Interest ↑Gap DownNBTXNanobiotix2.4857 of 5 stars$3.17-3.1%$8.00+152.4%-45.3%$149.41M$36.22M0.00100Gap DownDMACDiaMedica Therapeutics1.3138 of 5 stars$3.48-0.6%$8.00+129.9%+45.7%$149.14MN/A-6.2120Short Interest ↑Gap DownCGCCanopy Growth2.222 of 5 stars$0.93+1.1%$2.00+114.9%-86.8%$147.59M$276.75M-0.243,150News Coverage Remove Ads Related Companies and Tools Related Companies MediWound Alternatives Inventiva Alternatives Genfit Alternatives Rezolute Alternatives AC Immune Alternatives TuHURA Biosciences Alternatives DBV Technologies Alternatives Nanobiotix Alternatives DiaMedica Therapeutics Alternatives Canopy Growth Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OKUR) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OnKure Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share OnKure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OKUR Stock Free OKUR Stock Alerts